RDDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dr Reddy's Laboratories Ltd

Watchlist Manager

Watchlist

Price: 12.2 EUR -3.17%

Market Cap: €2B

D	Dr Reddy's Laboratories Ltd F:RDDA	IN
	Kairos Minerals Ltd ASX:KAI	AU
	Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	CN
V	VICI Properties Inc XMUN:1KN	US

Profitability Summary

Dr Reddy's Laboratories Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

66%

Strong 3Y Average Gross Margin

69%

Declining Gross Margin

71% > 66%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

22%

Declining Operating Margin

24% > 18%

Healthy Net Margin

16%

Sustainable 3Y Average Net Margin

18%

Declining Net Margin

18% > 16%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

15% > 5%

Positive ROE

17%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

20% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.